The Shingrix manufacturer GlaxosmithKline conducted clinical trials prior to product release but only for two doses. So how did GlaxosmithKline determine two doses are needed if they never ran a trial for a single dose? source:
https://pubmed.ncbi.nlm.nih.gov/33580242/